What if death wasn’t the end? Berlin-based startup Tomorrow Bio is exploring that question with its futuristic service—full-body cryopreservation. For $200,000 (approximately ₹1.74 crore), individuals can have their body cooled to extremely low temperatures immediately after legal death, with the hope that future medical technology may one day bring them back to life.
How It Works
Cryopreservation isn’t simple refrigeration. “Once you go under zero degrees, you don’t want to freeze the body; you want to cryopreserve it,” explains Emil Kendziorra, co-founder of Tomorrow Bio. The process involves replacing bodily fluids with cryoprotectants to prevent ice crystal formation, which can damage cells and tissues. Timing is crucial—Tomorrow Bio operates a 24/7 emergency standby team that initiates the procedure as soon as legal death is declared.
Current Reach and Future Plans
Tomorrow Bio has already cryopreserved a few humans and five pets. Nearly 700 people have signed up for the service. Currently operating in Europe, the company plans to expand operations across the United States in 2025. It’s Europe’s first cryonics lab, aiming to lead in both practical and research efforts related to cryopreservation.
Skepticism from the Scientific Community
Despite its ambitions, the science behind cryopreservation remains controversial. Critics argue that no human or complex organism has ever been revived after undergoing cryopreservation. Clive Coen, a professor of neuroscience at King’s College London, calls the concept “preposterous,” highlighting that there’s no scientific proof that human brain structures can survive and function post-preservation.
Techniques like nanotechnology and connectomics are often cited as future enablers of revival, but experts caution these are still theoretical and far from application.
Final Thoughts
Tomorrow Bio taps into the age-old human desire to cheat death. While it sparks hope and fascination, the lack of scientific evidence means cryopreservation remains firmly in the realm of speculation. Whether it’s visionary or merely science fiction dressed in a lab coat, only time—and perhaps the far future—will tell.
